FEDERATED HERMES, INC. - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 52 filers reported holding CARDLYTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of CARDLYTICS INC
ValueSharesWeighting
Q1 2023$437,459
-25.6%
128,854
+26.6%
0.00%
-50.0%
Q4 2022$588,132
-53.3%
101,753
-24.1%
0.00%
-50.0%
Q3 2022$1,260,000
+5900.0%
133,991
+14385.5%
0.00%
Q2 2022$21,000
-99.3%
925
-95.4%
0.00%
-100.0%
Q4 2020$2,855,000
+285400.0%
19,999
+222111.1%
0.01%
Q4 2019$1,000
-66.7%
9
-91.2%
0.00%
Q3 2019$3,000
-99.9%
102
-100.0%
0.00%
-100.0%
Q1 2018$5,852,000400,0000.02%
Other shareholders
CARDLYTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders